Related Experiment Videos
Characterization of endonucleolytic activity of HIV-1 integrase using a fluorogenic substrate
S P Lee1, M L Censullo, H G Kim
1Department of Biochemistry and Molecular Biology, Georgetown University Medical Center, Washington, DC 20007, USA.
Analytical Biochemistry
|May 20, 1995
Summary
A new fluorescence assay using FRET effectively measures HIV integrase activity. This method overcomes previous limitations and enables rapid screening of potential antiviral drugs targeting retroviral integration.
Area of Science:
- Biochemistry
- Molecular Biology
- Virology
Background:
- Retroviruses depend on reverse transcription and integration for their life cycle.
- HIV integrase (IN) protein is crucial for viral DNA integration into host chromosomes.
- Targeting HIV integrase is a key strategy for developing antiviral therapies.
Purpose of the Study:
- To develop a rapid and precise fluorescence assay for characterizing HIV integrase activity.
- To overcome limitations of previous fluorescence assays caused by fluorophore-DNA interactions.
- To facilitate the screening of novel HIV integrase inhibitors.
Main Methods:
- Utilized fluorescence resonance energy transfer (FRET) with fluorescein and eosin as the energy transfer pair.
- Employed a novel nucleotide analog with a 12-carbon linker arm to prevent fluorescence quenching.
- Measured HIV integrase-mediated DNA cleavage reactions using steady-state fluorescence studies.
- Validated the fluorescence assay results with autoradiographic analysis.
Main Results:
- The FRET-based assay successfully characterized HIV integrase-mediated DNA cleavage.
- Cleavage of the fluorogenic substrate by integrase led to enhanced donor fluorescence intensity.
- The assay demonstrated improved accuracy and sensitivity compared to previous methods.
- Autoradiographic analysis confirmed the fluorescence assay findings.
Conclusions:
- A robust FRET fluorescence assay for HIV integrase activity has been established.
- This assay provides a sensitive and efficient tool for kinetic studies and drug screening.
- The developed method overcomes previous technical challenges in fluorescence-based DNA assays.
- This work facilitates the discovery of new antiviral agents targeting retroviral integration.